We could not find any results for:
Make sure your spelling is correct or try broadening your search.
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Top Brokers
Investor discussions surrounding Oxford Biomedica Plc (OXB) during the week of December 10 to December 17, 2024, showcased a blend of expectation and concern regarding potential corporate maneuvers and share price developments. A recurring theme was speculation about mergers and acquisitions, particularly the possibility of Novo Holdings targeting OXB to bolster its gene therapy portfolio. The conversations highlighted differing valuations of the company, with some suggesting that OXB’s unique intellectual property, such as its patents on the LentiVector, could justify a premium over typical CDMO valuations, which often hover around 5x sales. One participant noted, "You can be sure of it Dom. The other thing you can be sure of is that the big boys will, as always, get their own way and make it happen their way," implying a confidence in institutional players driving the narrative.
Financial highlights from the discussion hinted at a solid year-to-date performance, with increases in share price of approximately 106%, leading to sentiment contrasting with fears of stagnation. Participants expressed optimism about OXB's growth potential, with remarks such as, "Indeed. My comment on wealth referred specifically to related investments in the CGT market... after many years," signaling a broader belief in the market for gene therapies reinventing wealth generation. However, recurring mentions of unusual trading patterns, such as "managed down again at close," and a locked trading range around £4.30 raised questions about market manipulation or insider strategies aiming to stabilize shares temporarily. Overall, investor sentiment appears cautiously optimistic, coupled with eagerness for upcoming announcements that could shape future share prices.
Show more
In recent announcements, Oxford Biomedica Plc (OXB), a leading CDMO specializing in cell and gene therapy, provided updates on its share capital, board changes, and upcoming webinar initiatives. As of November 30, 2024, OXB's issued share capital is reported at 105,938,933 ordinary shares, confirming that there are no shares held in treasury. This figure is critical for shareholders for determining their reporting obligations under the FCA's disclosure rules. Additionally, OXB recently appointed Colin Bond as a Non-Executive Director, effective January 1, 2025, as part of a succession plan for the board, enhancing its governance with Mr. Bond’s extensive experience in the biopharmaceutical sector.
Financially, OXB has been actively managing its equity structure, including granting long-term incentive plan (LTIP) awards to key personnel, which were scaled back by 20% to align with performance standards. The company is also engaging with stakeholders through a webinar on viral vector manufacturing scheduled for December 9, 2024, showcasing its capabilities in automated production processes. These initiatives reflect OXB’s commitment to remaining at the forefront of innovation within the biopharmaceutical industry while navigating corporate governance and financial reporting diligently.
Show more
I'm going to go into OXB OCD again here SJ, but the following may be of interest:- |
Columbia Threadneedle Management Limited is wholly owned by Columbia Threadneedle Holdings Limited, which is wholly owned by Columbia Threadneedle Group (Management) Limited, which is wholly owned by Columbia Threadneedle Group (Holdings) Limited, which is wholly owned by Columbia Threadneedle AM (Holdings) Plc, which is wholly owned by Columbia Threadneedle (Europe) Limited, which is wholly owned by Columbia Threadneedle Investments UK International Limited, which is wholly owned by Ameriprise Financial, Inc.which which which |
Well,i'll take it as reassuring without going too deeply into the rather opaque world of holding declarations.There can be an unsatisfactory delay between time of dealing and notification of a share holding and i would guess that this share purchase was the reason why the shares shot from 390 to around 440 in short order the week before last.It could be the large buyer which Dominic C understood was in the wings a fortnight back. |
No great surprise that low, and better than the techmark index I suppose :) |
Well spotted Cousin. |
So Columbia Threadneedle (per the RNS detail) were down as 3.06% in the OXB annual report, so have built another 2% over the last 6 months or so. Their business also now includes the old F&C/I&S/BMO funds but not sure where the OXB position held. |
Ameriprise Financial, Inc. is an American diversified financial services company and bank holding company based in Minneapolis, Minnesota.[1] It provides financial planning products and services, including wealth management, asset management, insurance, annuities, and estate planning.[1]As of April 2022, more than 80% of the company's revenue came from wealth management.[1][2]Ame |
Honestly never heard of them Tricky, but |
So our accumulator is unveiled. |
Not impossible - interesting just how few firms from the health sector are linked to FTSE 250...look at the big investors in this area e.g. Mercantile IT close to zero investment in this sector and as you look at all the other names it follows a very similar pattern. |
takeiteasy, |
Not all of us.... |
All this talk about US politics has scared all the OXB punters off today - they must read into this BB that the die hards have lost interest and are bored :) |
Time to let politics go and concentrate on our favourite subject, dear OXB. Til the morning, yn y bore! Looking forward to fireworks this week!!!! |
I promise to get back to OXB tomorrow and shut up about current events (or at least give it a try). |
I have never looked to political leaders to be examples of moral rectitude or providers of moral guidance.From feted heroes of distant history,to the likes of Lloyd George and JFK,flawed individuals have achieved power.I don't even expect to learn the complete truth.Russian missiles in Cuba in 63 but no mention of US missiles in Turkey,weapons of mass destruction in Iraq ,we are drip fed selective information so we will conclude what powerful lobbies,political and military,want us to believe.I'm not a conspiracy theorist but i do believe that the powers that be,invariably connive to keep the general public pretty much in the dark,exaggerating this and underplaying that,according to their agenda.A benign dictatorship seems increasingly acceptable in my advancing years :) |
sj, |
This is just a bit of oversimplified misinformation that is popular on twitter and actually stands up to very little scrutiny. |
Yes GJ , it's amazing that anyone with 34 felony convictions and a rape conviction, who incited an insurrection, sold "Top-Secret" files to foreign nations, and an inveterate lying thief could EVER be considered a candidate for POTUS. I guess we live and learn...🤔 |
The office of President of the USA should be greater than the President who holds it. Many poor presidents have at least held the office well. Others have demeaned the office they serve. |
Harry,Yes, I did watch the videos of the riots, and they very much confirmed all that I had read and seen before.Some people acted in what appeared to be almost bemused good nature, but others were out for blood. However, five people died, so it was serious, but Trump thought not. That sums him up. I'm a full blooded right of center libertarian, but could never support a man like that, even in the face of a Harris shaped alternative.And yes, you are right about the risks of Greece: like many previously communist led countries, it has history of expropriation! My (half hearted) musings have everything in excess of living expenses simply moved straight away from the SIPP into Overseas Bonds, domiciled in Guernsey, which would remove that risk. (Anyone else here got experience of those vehicles? SIPPs and ISA's have pushed them off the radar, but with labour in power I think that may change).And yes too to your observations regarding European migration: almost (?!) as much a mess as in the UK. At the moment, Greece (Crete) is home to a huge number of (illegal) migrants from Albania, Morocco, and Georgia. Everyone else moves on, hoping to get to Germany, Sweden or the UK, which are seen as the easy touches. |
red, |
Type | Ordinary Share |
Share ISIN | GB00BDFBVT43 |
Sector | Medicinal Chems,botanicl Pds |
Bid Price | 423.50 |
Offer Price | 428.00 |
Open | 412.00 |
Shares Traded | 305,331 |
Last Trade | 16:35:20 |
Low - High | 412.00 - 426.00 |
Turnover | 89.54M |
Profit | -184.16M |
EPS - Basic | -1.7479 |
PE Ratio | -2.43 |
Market Cap | 447.25M |
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Subscribe to Ad free and enjoy an ad-free experience
Try Now
Keep the Ads